On October 16th, Smoore International (06969.HK), a listed company on the Hong Kong Stock Exchange, announced that the U.S. Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) to R.J. Reynolds Vapor Company (RJR) regarding six flavors of their Vuse Alto brand e-cigarette products, including mint and mixed berry flavors. Smoore International has been notified by RJR that the temporary administrative stay of the Marketing Denial Order (MDO) has been approved, allowing the marketing and distribution of mint-flavored products to continue in the United States.
Smoore has announced that its board of directors has taken notice of the Marketing Denial Order (MDO) issued by the FDA to R.J. Reynolds Vapor Company (RJR) on October 12, 2023. This order pertains to six e-cigarette products under RJR's Vuse Alto brand, specifically the mint and mixed berry flavors. The company supplies mint-flavored products to RJR, which accounted for approximately 13% of the group's revenue between January 1, 2022, and September 30, 2023.
Smoore has announced that the board has taken note of RJR's intention to question MDOs and seek a temporary stay of execution. The company has also been informed by RJR that the temporary administrative stay for MDOs has been approved, allowing the marketing and distribution of mint-flavored products to continue in the United States. If the temporary stay is granted, mint-flavored products will be able to continue to be marketed and distributed in the United States. However, if RJR fails to obtain the temporary stay and the temporary administrative stay expires or is revoked, or if the MDOs are ultimately upheld, mint-flavored products may not be allowed to be marketed and distributed in the United States.
Smoore has stated that the company will closely monitor the situation and provide further updates as necessary.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
